INC Research to Connect with the Clinical Research Community at DIA 2016 Annual Meeting to Emphasize Collaboration in Bringing New Therapies to Market

RALEIGH, N.C., June 22, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, will demonstrate its continued commitment to making connections across the entire clinical development community with an extensive presence at the DIA 2016 52nd Annual Meeting June 26-29 in Philadelphia, Pennsylvania. INC Research thought leaders will be participating in educational sessions covering strategic partnerships, evolving methods in pain trials, risk-based monitoring and more. In addition, INC executives will be at Booth #2101 to discuss a range of topics impacting clinical development as well as the “Inspiring Hope” Ideathon, the Company’s strategic collaboration with the Center for Information and Study on Clinical Research Participation (CISCRP) focusing on promoting greater patient awareness and encouraging participation in clinical trials.

“We see DIA as a great forum for stakeholders across the research enterprise to share their views and insights on the latest innovations and best practices to accelerate and enhance clinical development,” said INC Research CEO Jamie Macdonald. “A significant portion of INC’s efforts over the last several years have centered on sites and patients and their importance in the drug development process. As an industry, we must continue to enhance our focus on these key stakeholders as valued partners in this process by placing their needs at the center of everything we do. We look forward to celebrating the contributions of clinical research sites at DIA again this year at our Annual Site Appreciation Reception and to furthering collaboration across the industry this fall at the 'Inspiring Hope' Ideathon, shining a light on the importance of clinical trials in bringing new medicines to market for patients in need.”

Contributing to the discussion at DIA
INC Research thought leaders will contribute to discussions at DIA on the following topics:

  • Elaine Taylor, Executive Director, Regulatory Consulting

#22: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing
Speaker Session, Sunday, June 26, 8:30 a.m.

  • Andrew Townshend, Senior Vice President, Alliance Development

#128: Alliance Management Forum
Speaker Session, Monday, June 27, 10:45 a.m.

  • Jill Collins, Executive Director, Clinical Innovation

#124: Risk-Based Monitoring in Clinical Trials
Speaker Session, Monday, June 27, 10:45 a.m.

  • Keith Barber, Executive Director, Process Quality Management

#144: Root Cause Analysis: Getting to ‘Why’ When Something Goes Wrong in Your Trial
Speaker Session, Monday, June 27, 10:45 a.m.

  • Dr. Galina Bernstein, Research Scientist, Pharmacokinetics, Scientific Affairs and Dr. Beatrice Setnik, Vice President, Clinical Pharmacology, Early Phase

#338: Evolving Methods in Pain Trials: Evaluating Abuse Deterrence, Drug Interactions, and Appropriate Patient Selection
Speaker Session, Wednesday, June 29, 2:00 p.m.

Celebrating the invaluable contributions of clinical research sites
INC Research is hosting its third annual Site Appreciation Reception for site representatives on Tuesday, June 28, from 5:30 to 8:30 p.m. The event, which recognizes the importance of clinical research sites to the drug development process, will be hosted by Executive Vice President, Corporate Strategy and Development Jean Chitwood and Vice President, Site and Patient Access, Clare Grace PhD. INC’s team will meet with clinical research site professionals to discuss ways to improve future collaborations for the benefit of patients. For more information on this event, interested sites should visit booth #2101. To view a video from last year’s DIA site event, click here.

Medical Heroes 5K Walk & Run
INC Research is an Elite Sponsor of CISCRP’s 5K Walk & Run taking place Monday, June 27, at 6:30 a.m. to coincide with the DIA 2016 Annual Meeting. A team of INC employees will take part in this important event to celebrate the volunteers who participate in clinical research, with proceeds supporting education and outreach programs to patients and families. To register or donate, visit

Connect with us
For more information or to schedule a meeting at DIA, visit the INC Research site, stop by Booth #2101 at the conference or connect with us on social media - Twitter, LinkedIn and Facebook.

About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries. For more information, please visit and connect with us on LinkedIn and Twitter @inc_research.

CONTACT: Investor Relations Contact: Ronnie Speight Vice President, Investor Relations Phone: +1 (919) 745-2745 Email: Press/Media Contact: Lori Dorer Senior Director, Corporate Communications Phone: +1 (513) 763-1380 Email:

Source:INC Research, LLC